CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 63.12% | +7.77% | — | |
| 2 | DSGN | Design Therapeutics INC | Stock-Other | 14.03% | -1.08% | — | |
| 3 | MLYS | Mineralys Therapeutics INC | Stock-Other | 10.47% | -3.40% | — | |
| 4 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 9.73% | -3.10% | +33.33% | |
| 5 | NKTX | Nkarta INC | Stock-Other | 1.76% | -0.10% | — | |
| 6 | ✓ | Effector Therapeutics INC | Stock-Other | 0.89% | — | — |